메뉴 건너뛰기




Volumn 27, Issue 5, 2012, Pages 1580-1586

Prognostic significance of p16 in locoregionally advanced head and neck cancer treated with concurrent 5-fluorouracil, hydroxyurea, cetuximab and intensity-modulated radiation therapy

Author keywords

Cetuximab; Chemoradiation; Epidermal growth factor receptor; Head and neck cancer; Intensity modulated radiation therapy

Indexed keywords

CETUXIMAB; CISPLATIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DOCETAXEL; FLUOROURACIL; HYDROXYUREA;

EID: 84858264302     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1679     Document Type: Article
Times cited : (7)

References (32)
  • 1
    • 51649093834 scopus 로고    scopus 로고
    • Recent advances in head and neck cancer
    • Haddad RI and Shin DM: Recent advances in head and neck cancer. N Engl J Med 359: 1143-1154, 2008.
    • (2008) N Engl J Med , vol.359 , pp. 1143-1154
    • Haddad, R.I.1    Shin, D.M.2
  • 2
    • 0037208591 scopus 로고    scopus 로고
    • An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer
    • Adelstein DJ, Li Y, Adams GL, et al: An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21: 92-98, 2003.
    • (2003) J Clin Oncol , vol.21 , pp. 92-98
    • Adelstein, D.J.1    Li, Y.2    Adams, G.L.3
  • 3
    • 73249143536 scopus 로고    scopus 로고
    • Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
    • Bonner JA, Harari PM, Giralt J, et al: Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol 11: 21-28, 2010.
    • (2010) Lancet Oncol , vol.11 , pp. 21-28
    • Bonner, J.A.1    Harari, P.M.2    Giralt, J.3
  • 9
    • 79952012758 scopus 로고    scopus 로고
    • Cisplatin-based chemoradiation plus cetuximab in locally advanced head and neck cancer: A phase II clinical study
    • Merlano M, Russi E, Benasso M, et al: Cisplatin-based chemoradiation plus cetuximab in locally advanced head and neck cancer: a phase II clinical study. Ann Oncol 22: 712-717, 2010.
    • (2010) Ann Oncol , vol.22 , pp. 712-717
    • Merlano, M.1    Russi, E.2    Benasso, M.3
  • 11
    • 77954737028 scopus 로고    scopus 로고
    • Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer
    • Cohen EE, Haraf DJ, Kunnavakkam R, et al: Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol 28: 3336-3343, 2010.
    • (2010) J Clin Oncol , vol.28 , pp. 3336-3343
    • Cohen, E.E.1    Haraf, D.J.2    Kunnavakkam, R.3
  • 12
    • 61449122062 scopus 로고    scopus 로고
    • Phase I study of lapatinib in combination with chemoradiation in patients with locally advanced squamous cell carcinoma of the head and neck
    • Harrington KJ, El-Hariry IA, Holford CS, et al: Phase I study of lapatinib in combination with chemoradiation in patients with locally advanced squamous cell carcinoma of the head and neck. J Clin Oncol 27: 1100-1107, 2009.
    • (2009) J Clin Oncol , vol.27 , pp. 1100-1107
    • Harrington, K.J.1    El-Hariry, I.A.2    Holford, C.S.3
  • 13
    • 78650968294 scopus 로고    scopus 로고
    • Phase 2 trial of concurrent 5-fluorouracil, hydroxyurea, cetuximab, and hyperfractionated intensity-modulated radiation therapy for locally advanced head and neck cancer
    • Kao J, Genden EM, Gupta V, et al: Phase 2 trial of concurrent 5-fluorouracil, hydroxyurea, cetuximab, and hyperfractionated intensity-modulated radiation therapy for locally advanced head and neck cancer. Cancer 117: 318-326, 2011.
    • (2011) Cancer , vol.117 , pp. 318-326
    • Kao, J.1    Genden, E.M.2    Gupta, V.3
  • 15
    • 77950332087 scopus 로고    scopus 로고
    • Do all patients with head and neck cancer benefit from radiotherapy and concurrent cetuximab?
    • Eriksen JG, Lassen P and Overgaard J: Do all patients with head and neck cancer benefit from radiotherapy and concurrent cetuximab? Lancet Oncol 11: 312-313, 2010.
    • (2010) Lancet Oncol , vol.11 , pp. 312-313
    • Eriksen, J.G.1    Lassen, P.2    Overgaard, J.3
  • 16
    • 13944263935 scopus 로고    scopus 로고
    • Human papillomavirus types in head and neck squamous cell carcinomas worldwide: A systemic review
    • DOI 10.1158/1055-9965.EPI-04-0551
    • Kreimer AR, Clifford GM, Boyle P, et al: Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14: 467-475, 2005. (Pubitemid 40270113)
    • (2005) Cancer Epidemiology Biomarkers and Prevention , vol.14 , Issue.2 , pp. 467-475
    • Kreimer, A.R.1    Clifford, G.M.2    Boyle, P.3    Franceschi, S.4
  • 17
    • 34247379040 scopus 로고    scopus 로고
    • Human papillomavirus and prognosis of oropharyngeal squamous cell carcinoma: Implications for clinical research in head and neck cancers
    • Gillison ML: Human papillomavirus and prognosis of oropharyngeal squamous cell carcinoma: implications for clinical research in head and neck cancers. J Clin Oncol 24: 5623-5625, 2006.
    • (2006) J Clin Oncol , vol.24 , pp. 5623-5625
    • Gillison, M.L.1
  • 18
    • 74949100842 scopus 로고    scopus 로고
    • Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma
    • Shi W, Kato H, Perez-Ordonez B, et al: Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma. J Clin Oncol 27: 6213-6221, 2009.
    • (2009) J Clin Oncol , vol.27 , pp. 6213-6221
    • Shi, W.1    Kato, H.2    Perez-Ordonez, B.3
  • 19
    • 74549123751 scopus 로고    scopus 로고
    • HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer
    • Lassen P, Eriksen JG, Hamilton-Dutoit S, et al: HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer. Radiother Oncol 94: 30-35, 2010.
    • (2010) Radiother Oncol , vol.94 , pp. 30-35
    • Lassen, P.1    Eriksen, J.G.2    Hamilton-Dutoit, S.3
  • 21
    • 70349275952 scopus 로고    scopus 로고
    • The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer
    • Kao J, Vu HL, Genden EM, et al: The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer. Cancer 115: 4586-4594, 2009.
    • (2009) Cancer , vol.115 , pp. 4586-4594
    • Kao, J.1    Vu, H.L.2    Genden, E.M.3
  • 22
    • 63149095503 scopus 로고    scopus 로고
    • Surrogate endpoints for overall survival in locally advanced head and neck cancer: Meta-analyses of individual patient data
    • Michiels S, Le Maitre A, Buyse M, et al: Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data. Lancet Oncol 10: 341-350, 2009.
    • (2009) Lancet Oncol , vol.10 , pp. 341-350
    • Michiels, S.1    Le Maitre, A.2    Buyse, M.3
  • 25
    • 77954190940 scopus 로고    scopus 로고
    • Human papillomavirus and survival of patients with oropharyngeal cancer
    • Ang KK, Harris J, Wheeler R, et al: Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363: 24-35, 2010.
    • (2010) N Engl J Med , vol.363 , pp. 24-35
    • Ang, K.K.1    Harris, J.2    Wheeler, R.3
  • 27
    • 73949129781 scopus 로고    scopus 로고
    • Predictors of competing mortality in advanced head and neck cancer
    • Mell LK, Dignam JJ, Salama JK, et al: Predictors of competing mortality in advanced head and neck cancer. J Clin Oncol 28: 15-20, 2010.
    • (2010) J Clin Oncol , vol.28 , pp. 15-20
    • Mell, L.K.1    Dignam, J.J.2    Salama, J.K.3
  • 28
    • 33646851264 scopus 로고    scopus 로고
    • Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: Preliminary experience and future directions
    • Milano MT, Vokes EE, Kao J, et al: Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions. Int J Oncol 28: 1141-1151, 2006.
    • (2006) Int J Oncol , vol.28 , pp. 1141-1151
    • Milano, M.T.1    Vokes, E.E.2    Kao, J.3
  • 29
    • 53049103005 scopus 로고    scopus 로고
    • Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: A multi-institutional phase II trial investigating three radiotherapy dose levels
    • Salama JK, Stenson KM, Kistner EO, et al: Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels. Ann Oncol 19: 1787-1794, 2008.
    • (2008) Ann Oncol , vol.19 , pp. 1787-1794
    • Salama, J.K.1    Stenson, K.M.2    Kistner, E.O.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.